Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments

被引：0
作者：
Wen Li
Shi-Chao Tang
Lei Jin
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Rheumatology and Immunology, Tongren Hospital
[2] Shanghai Jiao Tong University School of Medicine,Department of Rheumatology, Immunology & Allergy, Shanghai General Hospital
[3] Shanghai Jiao Tong University School of Medicine,undefined
来源：
BMC Pulmonary Medicine | / 24卷
关键词：
Mepolizumab; Benralizumab; Reslizumab; Anti-interleukin-5; Adverse events; Eosinophilic asthma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 27 条
  • [1] Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments
    Li, Wen
    Tang, Shi-Chao
    Jin, Lei
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [2] Exploring the risk of infection events in patients with asthma receiving anti-IL-5 monoclonal antibodies: A rapid systematic review and a meta-analysis
    Giossi, Riccardo
    Pani, Arianna
    Schroeder, Jan
    Scaglione, Francesco
    HELIYON, 2024, 10 (01)
  • [3] Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials
    Wang, Fa-Ping
    Xiong, Xiao-Feng
    Liu, Ting
    Li, Su-Yun
    Cheng, De-Yun
    Mao, Hui
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) : 318 - 330
  • [4] Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma
    Menigoz, C.
    Dirou, S.
    Chambellan, A.
    Hassoun, D.
    Moui, A.
    Magnan, A.
    Blanc, F. X.
    JOURNAL OF ASTHMA, 2023, 60 (06) : 1162 - 1170
  • [5] Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials
    Liu, Ting
    Wang, Faping
    Wang, Geng
    Mao, Hui
    FRONTIERS OF MEDICINE, 2018, 12 (03) : 340 - 349
  • [6] Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis
    Imran H. Iftikhar
    Mathew Schimmel
    William Bender
    Colin Swenson
    David Amrol
    Lung, 2018, 196 : 517 - 530
  • [7] Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis
    Iftikhar, Imran H.
    Schimmel, Mathew
    Bender, William
    Swenson, Colin
    Amrol, David
    LUNG, 2018, 196 (05) : 517 - 530
  • [8] Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma - a systematic review and meta-analysis
    Henriksen, Daniel P.
    Bodtger, Uffe
    Sidenius, Kirsten
    Maltbaek, Niels
    Pedersen, Lars
    Madsen, Hanne
    Andersson, Ehm A.
    Norgaard, Ole
    Madsen, Louise Klokker
    Chawes, Bo L.
    EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2018, 5 (01):
  • [9] Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials
    Ting Liu
    Faping Wang
    Geng Wang
    Hui Mao
    Frontiers of Medicine, 2018, 12 : 340 - 349
  • [10] Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials
    Fa-Ping Wang
    Xiao-Feng Xiong
    Ting Liu
    Su-Yun Li
    De-Yun Cheng
    Hui Mao
    Clinical Reviews in Allergy & Immunology, 2018, 54 : 318 - 330
123